Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma von Ahluwalia, Manmeet S, Reardon, David A, Abad, Ajay P, Curry, William T, Wong, Eric T, Figel, Sheila A, Mechtler, Laszlo L, Peereboom, David M, Hutson, Alan D, Withers, Henry G, Liu, Song, Belal, Ahmed N, Qiu, Jingxin, Mogensen, Kathleen M, Dharma, Sanam S, Dhawan, Andrew, Birkemeier, Meaghan T, Casucci, Danielle M, Ciesielski, Michael J, Fenstermaker, Robert A

Volltext

Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma von Ciesielski, Michael J, Ahluwalia, Manmeet Singh, Reardon, David A., Abad, Ajay P., Curry, William T., Wong, Eric T., Peereboom, David M., Figel, Sheila A., Hutson, Alan, Groman, Adrienne, Withers, Henry G., Liu, Song, Belal, Ahmed, Qiu, Jing-Xin, Mogensen, Kathleen, Schilero, Cathy, Casucci, Danielle M., Mechtler, Laszlo, Fenstermaker, Robert Alan

Volltext